Triamcinolone acetonide injection 80mg/2ml 

Therapeutic indications
Intramuscular:
The intramuscular administration of Triamcinolone Acetonide injection is indicated for systemic corticosteroid therapy in such conditions as allergic diseases, dermatoses, or generalised rheumatoid arthritis and other connective tissue disorders. Intramuscular administration is particularly valuable in such conditions when oral corticosteroid therapy is not feasible.
Intra-articular:
Triamcinolone Acetonide injection is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in; synovitis of osteoarthritis; rheumatoid arthritis; acute and subacute bursitis; acute gouty arthritis; epicondylitis; acute nonspecific tenosynovitis; post-traumatic osteoarthritis.
Dose and method of administration
administration
suitable for intramuscular, intra-articular and intra-synovial injection.
This formulation is not suitable for intravenous, intradermal or intraocular use.
Shake the vial before use to ensure a uniform suspension. After withdrawal, inject without delay to prevent settling in the syringe. Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing infection.
For adults and children over 12 years of age, the suggested initial dose is 60 mg, injected deeply into the gluteal muscle. Subcutaneous fat atrophy may occur if care is not taken to inject the preparation intramuscularly. Dosage is usually adjusted within the range of 40 to 80 mg, depending upon patient response and duration of relief. However, some patients may be well controlled on dosage as low as 20 mg or less. Patients with hay fever or pollen asthma who are not responding to pollen administration and other conventional therapy may obtain a remission of symptoms lasting throughout the pollen season after one injection of 40 to 100 mg.
For children from 6 to 12 years of age, the suggested initial dose is 40 mg, although dosage depends on the severity of symptoms than on age or weight. There is insufficient clinical experience with Kenacort-A 40 Injection to recommend its use in children under six years of age

****Follow all directions given to you by your doctor and pharmacist carefully

Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); Chemicals (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet requirements of Standard GMP and current BP,USP version.

We will spare no efforts to meet your demands!